Skip to main content
. 2022 Jun 27;13:951831. doi: 10.3389/fphar.2022.951831

FIGURE 9.

FIGURE 9

Effect of the SNM on molecular-targeted drugs inhibiting the subcutaneous growth of murine HCC cells in BalB/c mice. H22 cells were obtained and inoculated subcutaneously in BalB/c mice. Then, mice were given sorafenib (1, 5, 10 mg/kg) alone or combined with the SNM (0.2 g/kg). Photographs of subcutaneous tumors (A), tumor volume (B), and tumor weight (C) are shown. *p < 0.05.